BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24393953)

  • 1. [Long-term survival of a patient with locally advanced unresectable pancreatic cancer treated with gemcitabine after chemoradiation therapy].
    Chohno T; Aoki T; Hyuga S; Watanabe R; Matsumoto T; Takemoto H; Takachi K; Nishioka K; Uemura Y; Kobayashi K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1881-3. PubMed ID: 24393953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a case.
    Masui T; Doi R; Ogawa K; Kami K; Machimoto T; Seo S; Kawaguchi Y; Egawa H; Matsugu Y; Uemoto S
    Hepatogastroenterology; 2011; 58(110-111):1809-13. PubMed ID: 22086705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of unresectable advanced pancreatic tail cancer successfully treated with gemcitabine hydrochloride].
    Akutsu Y; Endo M; Yoshinaga Y; Hoshino T; Ota Y; Tsunoda Y; Matsubara H; Ochiai T
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):243-5. PubMed ID: 15751642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
    Barhoumi M; Mornex F; Bonnetain F; Rougier P; Mariette C; Bouché O; Bosset JF; Aparicio T; Mineur L; Azzedine A; Hammel P; Butel J; Stremsdoerfer N; Maingon P; Bedenne L; Chauffert B
    Cancer Radiother; 2011 Jun; 15(3):182-91. PubMed ID: 21315644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy.
    Takasawa O; Fujita N; Kobayashi G; Noda Y; Ito K; Horaguchi J
    World J Gastroenterol; 2006 Dec; 12(45):7299-303. PubMed ID: 17143944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of unresectable pancreatic cancer showing tumor dormancy treated with gemcitabine].
    Egawa T; Nagashima A; Kitano M; Doi M; Hayashi S; Yoshii H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1932-4. PubMed ID: 15553764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].
    Ohmura Y; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Monden M; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2428-9. PubMed ID: 20037445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine-based concurrent chemoradiotherapy versus chemotherapy alone in patients with locally advanced pancreatic cancer.
    Wang BH; Cao WM; Yu J; Wang XL
    Asian Pac J Cancer Prev; 2012; 13(5):2129-32. PubMed ID: 22901181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.
    Taira K; Boku N; Fukutomi A; Onozawa Y; Hironaka S; Yoshino T; Yasui H; Yamazaki K; Taku K; Hashimoto T; Nishimura T
    J Gastroenterol; 2008; 43(11):875-80. PubMed ID: 19012041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer.
    Mahadevan A; Jain S; Goldstein M; Miksad R; Pleskow D; Sawhney M; Brennan D; Callery M; Vollmer C
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):735-42. PubMed ID: 20171803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A long-term survivor case with good quality of life due to biliary bypass and gemcitabine for advanced pancreatic cancer].
    Maeyama R; Fukuyama T; Morimatsu K; Tamura T; Ishikawa N; Hachiya Y; Sako T; Hirano Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1873-5. PubMed ID: 18030028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
    Yajima T; Furukawa Y; Ishii Y; Hattori Y; Matsumoto N; Yamamoto M; Yamaoka Y; Fujihara M; Fujita M; Kuniki H
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):953-7. PubMed ID: 15222120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506.
    Ishii H; Furuse J; Boku N; Okusaka T; Ikeda M; Ohkawa S; Fukutomi A; Hamamoto Y; Nakamura K; Fukuda H;
    Jpn J Clin Oncol; 2010 Jun; 40(6):573-9. PubMed ID: 20185458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine therapy in patients with advanced pancreatic cancer.
    Min YJ; Joo KR; Park NH; Yun TK; Nah YW; Nam CW; Park JH
    Korean J Intern Med; 2002 Dec; 17(4):259-62. PubMed ID: 12647642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of radiotherapy for locally advanced pancreatic cancer.
    Sawaki A; Hoki N; Ito S; Matsumoto K; Mizuno N; Hara K; Takagi T; Kobayashi Y; Sawai Y; Kawai H; Tajika M; Nakamura T; Yamao K
    J Gastroenterol; 2009; 44(12):1209-14. PubMed ID: 19705054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
    Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
    JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A long survival case of unresectable pancreatic cancer by chemoradiotherapy with gemcitabine as key drug].
    Hirota M; Yagi Y; Yamashita K; Okamoto K; Sato T; Ichihara T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2413-6. PubMed ID: 19098414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of gemcitabine for locally advanced pancreatic cancer: comparison with 5-fluorouracil-based chemoradiotherapy.
    Tada M; Arizumi T; Nakai Y; Sasaki T; Kogure H; Togawa O; Matsubara S; Tsujino T; Hirano K; Sasahira N; Isayama H; Kawabe T; Omata M
    Chemotherapy; 2008; 54(4):302-8. PubMed ID: 18689983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer.
    Ma G; Sun Y; Fu S
    Int J Clin Exp Pathol; 2015; 8(10):13284-8. PubMed ID: 26722531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.